Neratinib - Puma Biotechnology
At a glance
- Drug Originator Wyeth
- Drug Licenced by Bixink Therapeutics; Knight Therapeutics; Medison Pharma; Pierre Fabre; Pint Pharma; Puma Biotechnology; Specialised Therapeutics Asia
- Drug Class Antineoplastics; Nitriles; Pyridines; Quinolines; Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists; ERBB 2 receptor antagonists; ERBB 4 receptor antagonists; Protein tyrosine kinase inhibitors
- USA Patent Applicants PUMA BIOTECH
- USA Patents 14
- NDAs 1
- International Patents 187
- Patent Applications 1,099
Table of Contents

Disclaimer